Matthew Gallagher, a 41-year-old entrepreneur from Los Angeles, has successfully built a telehealth company named Medvi with a revenue exceeding $2 billion solely through the strategic integration of artificial intelligence (AI) tools. The company primarily sells GLP-1 drugs, with AI playing a significant role in various operations such as website development, image creation, marketing materials, customer outreach, and support services.
Utilizing AI technologies like vibe coding, ChatGPT, Claude, Grok, Midjourney, Runway, and ElevenLabs, Matthew managed to automate crucial aspects of Medvi’s operations. Despite initially being the sole employee, he later brought his brother on board to assist in managing the rapidly growing company. Medvi, founded in September 2024 with an initial investment of $20,000, saw a remarkable revenue growth of $401 million in 2025, catering to approximately 250,000 clients. The company is projected to achieve around $1.8 billion in revenue for the year 2026.
Although Medvi’s success story has garnered attention, concerns have been raised regarding the legality of its operations as a telehealth company. By leveraging online doctor prescriptions, Medvi offers prescription drugs like GLP-1 medications at significantly lower costs compared to traditional healthcare providers. The company’s emphasis on GLP-1 drugs, known for their effectiveness in weight loss related to diabetes and obesity, has attracted a substantial customer base seeking affordable options.
Some industry experts, including Silicon Valley venture capitalist Sheel Mohnot, have raised suspicions about Medvi’s compliance with regulations. Mohnot suggested that Medvi’s marketing practices, involving numerous advertisements featuring potentially fake doctors and testimonials, could potentially violate laws. Furthermore, Medvi received a warning from American regulators in February, indicating possible regulatory breaches in its operations.
While AI has played a pivotal role in Medvi’s rapid growth and success, questions remain about the company’s adherence to legal standards within the telehealth industry. Matthew’s innovative use of AI tools has propelled Medvi into a significant player in the healthcare market, but the company’s compliance with regulations remains under scrutiny.
– Ends